|
Re: What happens when the database is locked?
|
6
|
Resverlogix Corp.
|
Sep 02, 2019 06:27PM
|
|
Re: Stability
|
6
|
Resverlogix Corp.
|
Nov 23, 2015 11:23AM
|
|
Resverlogix Plans COVID-19 Clinical Trial Program Launch
|
6
|
Resverlogix Corp.
|
Jun 01, 2020 09:38AM
|
|
Re: Genentech/Roche BET inhibitor toxicity paper
|
6
|
Resverlogix Corp.
|
Apr 20, 2016 11:12AM
|
|
Re: My guess is a second BTD is coming
|
6
|
Resverlogix Corp.
|
Feb 08, 2020 12:18PM
|
|
Re: Booyah ! I told you all!!
|
6
|
Resverlogix Corp.
|
May 15, 2019 11:27PM
|
|
Re: Resverlogix Announces Extension of Maturity Date of Loan and Expression of Interest Regarding Strategic Transaction
|
6
|
Resverlogix Corp.
|
Aug 28, 2017 08:53AM
|
|
Re: Success or Failure?
|
6
|
Resverlogix Corp.
|
Oct 06, 2019 09:03AM
|
|
Re: I think one major reason that,
|
6
|
Resverlogix Corp.
|
Nov 01, 2019 07:13PM
|
|
Re: Resverlogix Commences Dosing in Phase 3 Clinical Trial BETonMACE
|
6
|
Resverlogix Corp.
|
Nov 11, 2015 11:50AM
|
|
Re: Resverlogix Receives Approval From The FDA Cardiovascular and Renal Division To Proceed With A Requested Apabetalone Clinical Trial
|
6
|
Resverlogix Corp.
|
May 15, 2017 10:37AM
|
|
Re: Statistical Considerations
|
6
|
Resverlogix Corp.
|
Mar 08, 2018 11:07PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
6
|
Resverlogix Corp.
|
Jun 01, 2019 07:10PM
|
|
Safety and Efficacy at 9 months
|
6
|
Resverlogix Corp.
|
Aug 12, 2016 10:22AM
|
|
Re: Resverlogix's Twitter Account....
|
6
|
Resverlogix Corp.
|
Nov 05, 2017 10:34AM
|
|
Re: Esperion
|
6
|
Resverlogix Corp.
|
Feb 03, 2017 10:55AM
|
|
Re: Two investor conferences May 2
|
6
|
Resverlogix Corp.
|
May 01, 2016 02:42PM
|
|
Re: Additional Thoughts
|
6
|
Resverlogix Corp.
|
Oct 03, 2019 08:36AM
|
|
Re: Move Conversation To The "Uninteresting Forum"
|
6
|
Resverlogix Corp.
|
Sep 13, 2017 05:24PM
|
|
Abstract for American Diabetes Association presentation June 11, 2016
|
6
|
Resverlogix Corp.
|
Jun 05, 2016 05:34PM
|
